| Title |
Author(s) |
Journal |
Issue Date |
Type |
|
Buruli ulcer disease: prospects for a vaccine
|
Huygen, K.; Adjei, O.; Affolabi, D.; Bretzel, G.; Demangel, C.; Fleisher, B.; Johnson, R. C.; Pedrosa, J.; Phanzu, D. M.; Phillips, R. O.; Pluschke, G.; Siegmund, V.; Singh, M.; van der Werf, T. S.; Wansbrough-Jones, M.; Portaels, F.
|
Medical Microbiology and Immunology |
2009
|
Article
|
|
Mycobacterium ulcerans disease
|
van der Werf, T. S.; Stienstra, Y.; Johnson, R. C.; Phillips, R.; Adjei, O.; Fleischer, B.; Wansbrough-Jones, M. H.; Johnson, P. D. R.; Portaels, F.; van der Graaf, W. T. A.; Asiedu, K.
|
Bulletin of the World Health Organization |
2005
|
Article
|
|
In vitro activity of ciprofloxacin, sparfloxacin, ofloxacin, amikacin and rifampicin against Ghanaian isolates of Mycobacterium ulcerans
|
Thangaraj, H. S.; Adjei, O.; Allen, B. W.; Portaels, F.; Evans, M. R. W.; Banerjee, D. K.; Wansbrough-Jones, M. H.
|
Journal of Antimicrobial Chemotherapy |
2000
|
Article
|